Image source: nanthealth.com/dr-patrick-soon-shiong-honored-vatican-2016-pontifical-key-visionary-award/
Patrick Soon-Shiong (born July 29, 1952) is an American surgeon, billionaire businessman, and philanthropist. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of health and technology startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at the Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.Soon-Shiong is the chairman of the Chan Soon-Shiong Family Foundation, the Chan Soon-Shiong Institute for Advanced Health, and the Healthcare Transformation Institute. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and Executive Chairman of the Los Angeles Times and The San Diego Union-Tribune. In April 2016, the Los Angeles Times reported him to be one of the highest-paid CEOs of 2015. As of September 2019, Soon-Shiong was estimated by Forbes as having a net worth of US$6.6billion.